Analysis: Excel Industries Limited

NSE:EXCELINDUS Pesticides/Agrochemicals Market cap: ₹1.3K cr

What does Excel Industries Limited do?

  • Excel Industries Ltd is one of India's oldest chemical companies, established in 1941, specializing in phosphorus chemistry and specialty chemicals.
  • Operates across agrochemical intermediates, yellow phosphorus derivatives, performance solutions, and pharma intermediates/APIs.
  • Headquartered in Mumbai, with manufacturing sites in Roha, Lote Parshuram (Maharashtra), and Visakhapatnam (Andhra Pradesh).
  • Agrochemical intermediates (50-60% of revenue), including backward-integrated phosphorus-based products.
  • Performance Solutions (25-30% of revenue): phosphonates, biocides, mining chemicals, polymer inputs, and functional additives.
  • Yellow Phosphorus (YP) derivatives (7-10% of revenue) for industrial and agrochemical applications.
  • Pharma intermediates/APIs (6-8% of revenue) with niche, fully backward-integrated production.
  • Contract manufacturing agreements (CMO) for specialty chemicals, including a 5-year, ₹35-40 crore contract announced in FY26.

Growth thesis

Excel Industries is a phosphorus-based specialty chemicals company with core segments in agrochemical intermediates (50-60% revenue), performance solutions (25-30%), and pharma intermediates. Growth is driven by a 35-40 crores/year contract manufacturing deal (commissioned July 2026) and biocide capacity expansion (15 crores incremental revenue). Rs 200-300 crores of capex over three years targets 1.0-1.5x asset turnover and 15-20% ROI, with EBITDA margins rising to 13-15% as capacity utilization improves to 85-90%. Over 2-3 years, Performance Solutions and EU market expansion via India-EU FTA will diversify revenue, while backward integration and margin-accretive contracts reduce agrochemical dependence. Key execution risk: timely July 2026 commissioning of the contract manufacturing line.

Why is Excel Industries Limited stock rising?

  • Commissioning of dedicated line for contract manufacturing long-term agreement expected by July 2026
  • Plan to launch one new biocide product in the second half of FY27
  • New corporate R&D center at Rabale operationalized to strengthen growth across all verticals
  • Growth areas identified: Performance Solutions, contract manufacturing, and YP derivatives
  • Capex of INR200-300 crores over next three years including maintenance and growth, with expected fixed asset turnover of 1-1.5x and ROI of 15-20%

Research report

companyname: Excel Industries Limited ticker: EXCELINDUS sector: Specialty Chemicals / Agrochemical Intermediates Excel Industries Limited is one of India's oldest chemical companies, with a manufacturing legacy dating back to 1941 and a pioneering role in phosphorus chemistry. It is not a generic commodity chemical maker. The company operates across four major product groups within specialty chemicals — Agrochemical intermediates, Yellow Phosphorus (YP) derivatives, Performance Solutions, and ...

Read the full report →

Catalysts

capex, margin expansion, new product segment, geographic expansion

Growth guidance

FY27 revenue growth driven by new contract manufacturing agreement (35-40 crores annual revenue) and biocide capacity expansion (15 crores incremental revenue)

Guidance maintained
RS rating: 61 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Excel Industries Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.